Chronic muco-cutaneous candidiasis: new approaches to treatment.
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents; D001555:Benzene Derivatives / Q000627:therapeutic use; D002179:Candidiasis, Cutaneous / Q000145:classification / Q000188:drug therapy* / Q000276:immunology; D002908:Chronic Disease; D003596:Cytosine / Q000627:therapeutic use; D005459:Fluorides / Q000627:therapeutic use; D006649:Histocompatibility Antigens; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007070:Immunoglobulin A; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007275:Injections, Intravenous; D007501:Iron / Q000627:therapeutic use; D007962:Leukocytes; D008297:Male
D000935:Antifungal Agents; D001555:Benzene Derivatives; D006649:Histocompatibility Antigens; D007093:Imidazoles; D007070:Immunoglobulin A; D000666:Amphotericin B; D003596:Cytosine; D007501:Iron; D005459:Fluorides